-
r37980778c78--dd2f670638b2baa39af7c805d7d516f3
Correlations between ASEBA and BRIEF-A self-report for the ADHD group and the healthy control group, and between the ADHD patients' ASEBA and BRIEF-A informant-report. -
Behavioral results on the T.O.V.A. for ADHD patients and healthy controls.
Behavioral results on the T.O.V.A. for ADHD patients and healthy controls. -
Performance on go/no-go tasks.
Values are described as means ± standard deviation a two-sample t-test comparing score changes (post-intervention minus pre-intervention scores) between groups, by tasks b... -
Summary of multiple regression models predicting ADHD self- and informant rep...
Summary of multiple regression models predicting ADHD self- and informant report scores on the BRIEF-A Organization of Materials scale from the patients' T.O.V.A. reaction time... -
BRIEF-A and ASEBA self- and informant report for ADHD patients, and self-repo...
BRIEF-A and ASEBA self- and informant report for ADHD patients, and self-report for healthy controls. -
Demographic and Clinical Characteristics at Baseline.
a Age presented as mean ± standard deviation (SD) b MMSE (Mini-Mental State Examination) described as mean ± SD c According to the criteria of the Diagnostic and Statistical... -
Participant demographics and T-scores on the ASEBA Adult-Self-Report (ASR) DS...
Participant demographics and T-scores on the ASEBA Adult-Self-Report (ASR) DSM ADHD Problems scale. -
r37980778c78--b5554251eee5cb9a15712fcf3e24ffaf
Correlations of T.O.V.A. performance with BRIEF-A and ASEBA DSM self-report for the ADHD group and the healthy control group, and of the ADHD patients' T.O.V.A. performance with... -
Characteristics of groups with different treatment duration of methylphenidate.
Characteristics of groups with different treatment duration of methylphenidate. -
A Randomized, Double-Blind, Sham-Controlled Trial of Transcranial Direct Curr...
BackgroundCurrent standardized treatments for cognitive impairment in attention-deficit/hyperactivity disorder remain limited and their efficacy restricted. Transcranial direct...